000			02132 a2200589 4500
005			20250518014223.0
264		0	_c20191029
008			201910s 0 0 eng d
022			_a2044-6055
024	7		_a10.1136/bmjopen-2018-023115 _2doi
040			_aNLM _beng _cNLM
100	1		_aCampbell, Aideen M
245	0	0	_aChemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment. _h[electronic resource]
260			_bBMJ open _c12 2018
300			_ae023115 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnastrozole _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemoprevention _xmethods
650	0	4	_aCross-Over Studies
650	0	4	_aDisease-Free Survival
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aGenetic Predisposition to Disease _xepidemiology
650	0	4	_aGoserelin _xtherapeutic use
650	0	4	_aHeterozygote
650	0	4	_aHumans
650	0	4	_aMutation
650	0	4	_aNorthern Ireland
650	0	4	_aPatient Acceptance of Health Care _xstatistics & numerical data
650	0	4	_aPatient Selection
650	0	4	_aPremenopause _xphysiology
650	0	4	_aPrognosis
650	0	4	_aRisk Assessment
650	0	4	_aSurvival Rate
650	0	4	_aTamoxifen _xtherapeutic use
650	0	4	_aTreatment Outcome
650	0	4	_aUbiquitin-Protein Ligases _xgenetics
700	1		_aMorris, Melanie
700	1		_aGallagher, Rebecca
700	1		_aBoyd, Ruth
700	1		_aCarson, Hazel
700	1		_aHarkin, D Paul
700	1		_aWielogorska, Ewa
700	1		_aElliott, Christopher
700	1		_aSavage, Kienan I
700	1		_aMcIntosh, Stuart A
773	0		_tBMJ open _gvol. 8 _gno. 12 _gp. e023115
856	4	0	_uhttps://doi.org/10.1136/bmjopen-2018-023115 _zAvailable from publisher's website
999			_c29192667 _d29192667